Every Dollar Has Direction
Investors often think of capital as neutral until it reaches the company. It is not. Capital arrives with expectations: growth rate, exit timeline, margin pressure, governance, risk tolerance, and definitions of success.
Those expectations shape product decisions long before a public scandal or policy debate appears.
Patient Capital Builds Different Products
A five-year holding period and a twenty-year holding period produce different companies. A product optimized for rapid user growth may accept harms that a long-term owner would recognize as trust destruction.
Patient capital can afford to ask whether the user relationship is getting stronger, whether the brand is becoming trusted, and whether the company is building durable human value rather than temporary capture.
Technology share of U.S. public equity markets, 1900-2025
Broad technology concentration compared with the strict IT sector share.
Moral Return Is Not Anti-Return
Technology remains one of the highest-leverage places to invest because software scales, distribution compounds, and AI can expand capability quickly. The question is not whether morally serious investors should avoid technology. It is whether they can afford to keep ignoring it.
If technology is shaping children, labor, attention, commerce, and knowledge, then capital formation in technology is also culture formation.
Questions For The Diligence Room
Investors should ask: does the business model depend on addiction, opacity, or user lock-in? What human good does the product strengthen? What would the company refuse to do for growth? How are children protected? How portable is the user's data and identity? What metric proves users are better off?
Capital is a vote for what gets built. Cast it accordingly.